Eli Lilly Most Successful Drugs

Lilly's weight loss drug shortage deemed over

Eli Lilly weight loss drug shortage underscores deeper issues with FDA oversight

A turbulent series of events around the supply of Eli Lilly’s blockbuster weight loss treatment has raised concerns around how the FDA maintains its list of drug shortages.

GlobalData on MSN · 2d

MangoRx hits back at Eli Lilly’s weight loss drug copycat claims

MangoRx was responding to Eli Lily after the drugmaker sued it and two other medical spas and online vendors earlier this week for selling products claiming to contain tirzepatide

USA TODAY on MSN · 3d

Eli Lilly sues over knockoffs of signature weight loss drug, Zepbound

Eli Lilly sued three medical spas and online vendors for selling products that claim to contain the ingredient in its weight-loss medicine Zepbound.

CBS News on MSN · 1d

Lilly's weight loss drug shortage deemed over, but hurdles remain

Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

Eli Lilly Alzheimer’s drug rejected

Wall Street Journal · 1d

England’s Drug-Cost Watchdog Rejects Eli Lilly’s Alzheimer’s Drug

Regulator cited significant uncertainties about the drug’s benefits, as well as the high costs to treat its severe side effects.

Business Insider · 1d

Eli Lilly Alzheimer’s drug rejected as too expensive by UK’s NHS, FT reports

The UK’s healthcare spending watchdog has rejected Eli Lilly’s (LLY) Alzheimer’s drug as being too expensive despite being

The Financial Times · 1d

Live news: Second Alzheimer’s drug deemed too expensive for UK’s NHS

Keep abreast of significant corporate, financial and political developments around the world. Stay informed and spot emerging risks and opportunities with independent global reporting, expert commentary and analysis you can trust.

2don MSN

This Setback for Johnson & Johnson Is 1 More Green Light for Eli Lilly's Stock

And it looks like Johnson & Johnson (NYSE: JNJ) just hit a bump in the road that'll pave the way for Eli Lilly (NYSE: LLY) to ...

The Economist1d

It’s not just obesity. Drugs like Ozempic will change the world

First the drugs tackled diabetes. Then, with just an injection a week, they took on obesity. Now they are being found to ...

pharmaphorum1d

Novo joins Lilly in asking FDA for ban on GLP-1 compounding

Under US law, compounding pharmacies can make and sell patent-protected drugs that are on the FDA's shortages list in limited ...

Reuters3d

Lilly sues online vendors, medical spa over copycat weight-loss drugs

In its most recent filings ... to an unjustifiable risk of harm." Eli Lilly is seeking court orders barring the vendors from selling their drugs claiming to contain tirzepatide and unspecified ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results